| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of Pleural Carcinoembryonic Antigen (CEA) Assay in Patients with Benign and Malignant Pleural Effusions Requiring Thoracentesis
|
Lumachi, F.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 2 |
A Common Bim Deletion Polymorphism was Associated with the Risk of Lung Cancer in a Chinese Population
|
Jing, X.J.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 3 |
Adequacy of Lymph Node Sampling During Surgical Resection of Lung Cancer at a Regional UK Thoracic Surgical Centre 2011-2013
|
Evison, M.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 4 |
Advantages of Diffusion Weighted Imaging of Pulmonary Nodules and Masses: Comparison with Positron Emission Tomography
|
Usuda, K.
|
|
|
26 |
S1 |
p. i15
|
artikel
|
| 5 |
Afatinib (A) Plus Paclitaxel (P) Following Progression on a Monotherapy in Patients (PTS) with Metastatic Non–Small-Cell Lung Cancer (NSCLC) Who Previously Benefited From Erlotinib (E)/Gefitinib (G): a Global Randomised Phase Iii Trial–Lux-Lung 5 (LL5)
|
Schuler, M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 6 |
Afatinib (A) Vs Erlotinib (E) as Second-Line Treatment of Patients (PTS) with Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (LL8), a Phase Iii Global Trial
|
Goss, G.D.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 7 |
Allele Frequency of Abo and Rh Blood Group and the Risk of Non Small Cell Lung Carcinoma
|
Kapoor, A.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 8 |
A Molecular Case–Control Investigation of the Merkel Cell Polyomavirus Prevalence in Vietnamese Non-Small-Cell Lung-Cancer
|
Ngo, T.T.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 9 |
Analysis of Local Recurrences Following Stereotactic Ablative Radiotherapy (SABR): Data From a Large Institutional Database
|
Verstegen, N.E.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 10 |
Anatomical Resection Improves Survival Over Wedge Resection of Pulmonary Metastases of Colorectal Origin in the Spanish Prospective Multicenter Study (GECMP-CCR)
|
Molins, L.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 11 |
An Estimation of the Population-Based Survival Benefit of First-Line Chemotherapy for Lung Cancer
|
Do, V.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 12 |
An Integrative Analysis of the Putative Gefitinib-Resistant Genes in a Lung Cancer Cell Line Model System
|
Han, X.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 13 |
Anlotinib as Third-Line Treatment in Patients with Refractory Advanced Non-Small Cell Lung Cancer: a Multicentre, Randomized, Double-Blind, Placebo-Controlled, Phase Ii Trial (NCT01924195)
|
Han, B.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 14 |
A Novel Technique for the Management of Reccurent Malignant Pericardial Effusions
|
Panagiotopoulos, N.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 15 |
Anterior Mediastinal Mass Case Series
|
Ramanathan, P.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 16 |
Antitumor Efficacy of the Double Suicide Genes in Lung Cancer Cells
|
Shen, C.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 17 |
A Phase 1B Study of Anti-Dll4 (DELTA-LIKE LIGAND 4) Antibody Demcizumab (DEM) with Pemetrexed (PEM) and Carboplatin (CARBO) in Patients with 1St-Line Non-Squamous Nsclc
|
Dupont, J.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 18 |
A Phase I Study of AZD9291 in Patients with Egfr-Tki-Resistant Advanced Nsclc – Updated Progression Free Survival and Duration of Response Data
|
Jänne, P.A.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 19 |
A Phase 3, Randomised, Double-Blind, Placebo-Controlled, International Study of Medi4736 in Patients with Locally Advanced, Unresectable, Stage 3 Nsclc Who Have not Progressed Following Platinum-Based, Concurrent Chemoradiation Therapy (PACIFIC)
|
Creelan, B.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 20 |
A Prospective Randomized Open Label Phase III Study of Geftinib Versus Docetaxel as Second or Third Line Therapy in Patients with Advanced Non Small Cell Lung Cancer in Asian Indians
|
Kapoor, A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 21 |
A Prospective Randomized Open Label Phase III Study of Maintenance Gemcitabine Versus Best Supportive Care Following Platinum-Paclitaxel Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
|
Jakhar, S.L.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 22 |
A Prospective Randomized Phase III Study Evaluating Quality of Life in Advanced Non-Small Cell Lung Cancer Receiving Platinum Based Chemotherapy Combination in Old Versus New Standard Chemotherapy Regimen
|
Rungta, A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 23 |
A Prospective Randomized Phase Iii Study of Palliative Chemotherapy Versus Best Supportive Care in Elderly Patients with Advanced Non-Small Cell Lung Cancer: Survival Analysis and Ecog Performance Status Regression Analysis
|
Kumar, N.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 24 |
A Randomized, Double-Blind, Phase 2 Trial of Veliparib (ABT-888) with Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer
|
Mazieres, J.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 25 |
AURA3 Design: a Randomised, Phase III Study of Azd9291 Versus Second-Line Chemotherapy for Patients (PTS) with Egfr-Tki-Resistant (T790M) Advanced Non-Small Cell Lung Cancer
|
Wu, Y.-L.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 26 |
Azd9291, a Third Generation EGFR Inhibitor, Versus Gefitinib or Erlotinib in Treatment-Naïve Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC) Harbouring an Egfr-Tki-Sensitising Mutation (EGFRM): a Randomised, Phase Iii Study (FLAURA)
|
Ramalingam, S.S.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 27 |
Biological Role of Prognostic Micrornas (MIRNAS) in Squamous Lung Carcinoma (SCC) Cells
|
Filipska, M.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 28 |
Body Mass Index and Lung Cancer Survival: Results From the Icare Study
|
Sanikini, H.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 29 |
Can Concurrent Chemo-Radiation Be Delayed by Induction Chemotherapy in the Curative Treatment of Stage Iii Non-Small Cell Lung Carcinoma? a Pooled Analysis
|
Guilbault, C.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 30 |
Ceritinib in Patients (PTS) with Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Metastatic to the Brain and/or Leptomeninges: the Phase II Ascend-7 Study
|
Chow, L.Q.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 31 |
Ceritinib Treatment of Patients (PTS) with Alk-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases: Ascend-1 Trial Experience
|
Kim, D.-W.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 32 |
Characteristics of Lung Cancer Diagnosed with Low Dose Chest CT Screening
|
Choi, S.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 33 |
Chemotherapy of Malignant Pleural Mesothelioma Does not Preclude Use of Check-Point Blockade
|
Curioni Fontecedro, A.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 34 |
Clinical Characteristics and Response to EGFR TKI in Never Smoker Squamous Lung Cancer
|
Ee, S.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 35 |
Clinical Factors of Nodal Upstaging in Pathologic N1 Or N2 Non-Small Cell Lung Cancer
|
Moon, Y.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 36 |
Clinicopathological Analysis of Primary Pulmonary Lymphoepithelioma-Like Carcinoma
|
Shen, C.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 37 |
Comparison of Clinical Outcome of Stage I Non-Small Cell Lung Cancer Treated Surgically Or with Stereotactic Radiotherapy: Results From Propensity Score Analysis
|
Mokhles, S.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 38 |
Comparison of Efficacy of Pemetrexed Plus Platinum and Non-Pemetrexed Plus Platinum as 1St Line Chemotherapy in EGFR Wild Type Non-Squamous Nsclc
|
Kang, E.J.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 39 |
Comprehensive Analysis of Driver Mutations in Chinese Squamous Cell Lung Carcinomas By Targeted Next-Generation Sequencing
|
Shi, Y.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 40 |
Concurrent Chemoradiotherapy with Vinorelbine Plus Split-Dose Cisplatin in Inoperable Stage Iii Non-Small Cell Lung Cancer
|
Mertsoylu, H.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 41 |
Ct Characteristics Allow the Identification of Patient-Specific and Regional Susceptibility for Radiation-Induced Lung Damage
|
Defraene, G.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 42 |
Definitive Concomitant Radiochemotherapy (RCT) Treatment for Locally Advanced (LA) Non Small Cell Lung Cancer (NSCLC): Evaluation of Hematological and Esophageal Toxicity in the Radiation Oncology Department of University of Florence Experience
|
Scotti, V.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 43 |
Detection of Circulating Tumor Cells and Early Recurrence in Patients Undergoing Radical Resection for Non-Small-Cell Lung Cancer
|
Bayarri-Lara, C.I.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 44 |
Detection of EGFR T790M Mutation in Urinary Circulating Tumor Dna From Metastatic Non-Small Cell Lung Cancer Patients
|
Husain, H.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 45 |
Determining the Prevalence of EGFR Mutations in Asian and Russian Patients (PTS) with Advanced Non-Small-Cell Lung Cancer (ANSCLC) of Adenocarcinoma (ADC) and Non-Adc Histology: Ignite Study
|
Han, B.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 46 |
Development of Resistance Models to Tyrosine Kinase Inhibitors (TKIS) in Patient-Derived Xenograft Models (PDXS) of Lung Adenocarcinoma with Epidermal Growth Factor Receptor (EGFR) Mutations
|
Stewart, E.L.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 47 |
Different Metastatic Pattern According to the EGFR Mutational Status in a Cohort of Lung Adenocarcinomas (ADCS): a Single-Institution Report
|
Russo, A.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 48 |
“Different Trend” in Multiple Primary Lung Cancer and Intrapulmonary Metastasis
|
Shen, C.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 49 |
Distribution of T Cells in Non-Small Cell Lung Cancer Tissue According to Copd and Smoking Status
|
Jackute, J.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 50 |
Does a Higher Surgical Resection Rate in Lung Cancer Lead to a Higher Rate of Post-Operative Multi-Station N2 Disease?
|
Evison, M.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 51 |
Drug Index
|
|
|
|
26 |
S1 |
p. i55
|
artikel
|
| 52 |
Duration and Tolerance of Maintenance Pemetrexed (MPEM) Treatment for Advanced Non-Small Cell Lung Cancer
|
Charlton, P.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 53 |
Editorial Board
|
|
|
|
26 |
S1 |
p. ii-iii
|
artikel
|
| 54 |
Effectiveness of First-Line Pemetrexed Plus Platinum for Advanced Nonsquamous Non-Small Cell Lung Cancer
|
Brandão, M.D.R.A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 55 |
Effect of Comorbidity on Surgery and Survival Among Lung Cancer Patients in England
|
Lüchtenborg, M.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 56 |
Effect of Haematological Adverse Effects Occuring During Chemotherapy on Response to Treatment and Progression Free Survival in Advanced Nsclc
|
Nagy, A.A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 57 |
Efficacy and Safety of Imprime Pgg, a Novel Innate Immune Modulator, in Combination with Bevacizumab (BEV), Carboplatin and Paclitaxel for the 1St-Line Treatment of Stage Iv Nsclc
|
Braun, A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 58 |
EGFR Mutant Subset Analysis From Archer 1009: a Randomized Double Blind Phase 3 Efficacy and Safety Study of Dacomitinib Versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
|
Paz-Ares, L.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 59 |
EGFR Mutation Detection in Plasma of Lung Tumor Patients in the Absence of Contributive Tissue is a Relevant Alternative for Prescription of Tyrosine Kinase Inhibitors in a Routine Clinical Setting
|
Denis, M.G.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 60 |
EGFR Mutation is not a Rare Issue for Peripheral Squamous Carcinoma of Lung
|
Zhang, Q.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 61 |
EGFR Mutations in Non-Small Cell Lung Cancer in South Africa
|
Chan, S.W.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 62 |
EGFR Mutation Testing and Oncologist Treatment Choice in Advanced Nsclc: Global Trends and Differences
|
Spicer, J.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 63 |
Enumeration and Molecular Characterization of Circulating Tumor Cells in Lung Cancer Patients Using the Gilupi Cellcollector™, An Effective in Vivo Device for Capturing Ctcs
|
Scheumann, N.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 64 |
Epidemiology, Treatment Patterns and Survival Outcome in Patients of Advanced Stage Inoperable Lung Cancer: a Tertiary Cancer Care Centre Analysis
|
Kumar, D.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 65 |
Erlotinib as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Phase Iiib Study
|
Zaric, B.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 66 |
Erlotinib as Neoadjuvant Treatment in Endobronchial Ultrasound Confirmed Stage IIIA-N2 Non-Small Cell Lung Cancer (NSCLC) Patients with Epidermal Growth Factor Receptor (EGFR) Mutation (EXON 19 OR 21) (NCT01217619, ESTERN): a Prospective, Single Arm, Phase Ii Clinical Trial
|
Han, B.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 67 |
European Lung Cancer Conference (ELCC) 2015 Organisation
|
|
|
|
26 |
S1 |
p. xi-xii
|
artikel
|
| 68 |
European Society for Radiotherapy and Oncology (ESTRO)
|
|
|
|
26 |
S1 |
p. viii-ix
|
artikel
|
| 69 |
European Society of Thoracic Surgeons (ESTS)
|
|
|
|
26 |
S1 |
p. x
|
artikel
|
| 70 |
Evaluation of Anaplastic Lymphoma Kinase (ALK) Inhibitor Brigatinib [AP26113] in Patients (PTS) with Alk+ Non–Small Cell Lung Cancer (NSCLC) and Brain Metastases
|
Kerstein, D.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 71 |
Examination of Prognostic Factors in Cases Receiving UFT as Postoperative Adjuvant Chemotherapy for Lung Cancer
|
Nawa, K.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 72 |
Expression of IRAK-1 and EZH-2 in Imprints of Nsclc and Preneoplastic Lesions
|
Hainis, K.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 73 |
Factors Affecting Survival in Patients with Pulmonary Metastases from Colorectal Cancer with Previously Resected Liver Metastases Who Underwent Lung Metastasectomy
|
Lumachi, F.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 74 |
FDG PET/CT for Evaluation of Mediastinal Lymph Node Staging Using FDG UPTAKE and Volumetric Ct Histogram in Non-Small Cell Lung Cancer
|
Lee, J.W.
|
|
|
26 |
S1 |
p. i15
|
artikel
|
| 75 |
Feasiblity of Endoscopic Transumbilical Anatomic Lobectomy in a Canine Model
|
Liu, Y.-H.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 76 |
Fine Needle Aspiration Cytology of Thymic Epithelial Neoplasms: a Cytologic-Histologic Correlation Analysis From a Referral Institution
|
Templo, F.J.S.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 77 |
Frequency of ALK Gene Rearrangement in Saudi Lung Cancer
|
Al Dayel, F.H.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 78 |
Gef Gene: a New Suicide Gene Therapy for Non-Small Cell Lung Cancer
|
Rama Ballesteros, A.R.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 79 |
German Country-Wide Surveys from 2012 and 2014 About EGFR Mutational Testing Algorithms Adopted by Medical Doctors in Patients with Nsclc
|
Ostermann, H.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 80 |
History of the International Association for the Study of Lung Cancer (IASLC)
|
|
|
|
26 |
S1 |
p. vii
|
artikel
|
| 81 |
Icotinib as First-Line Treatment for Elderly Patients with EGFR 19 or 21 Mutation in Advanced Nsclc: a Phase-Iv, Open-Label, Single-Arm Study
|
Han, B.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 82 |
Identifying the Genetic Landscape of Squamous Cell Carcinoma (SCC) and Adenosquamous Carcinoma (ASC) of the Lung Using Next-Generation Sequencing (NGS)
|
Chilingirova, N.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 83 |
Idiopathic Pulmonary Fibrosis As a Poor Prognostic Factor in Lung Cancer Patients
|
Son, C.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 84 |
Immune Checkpoints Score and CD8+ T Cells Infiltration Are Independent Prognostic Biomarkers in Resected Nsclc
|
Usó, M.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 85 |
Impact of Maintenance Pemetrexed in the Management of Non-Progressing Malignant Mesotheliomas After Standard Fist-Line Chemotherapy: a Single Institution Experience
|
Franchina, T.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 86 |
Improved Quality of Life of Patients with Malignant Pleural Effusion Who Underwent Video-Assisted Minimally Invasive Thoracentesis and Talc Pleurodesis
|
Lumachi, F.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 87 |
Incidence of Brain Metastases Identified Upon Initial Diagnosis in Different Histological Types of Lung Cancer: a Single Department Experience
|
Drpa, G.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 88 |
Incidence of Pain Among Lung Cancer Patients Hospitalized in Palliative Care Department of Comprehensive Cancer Center – Vratsa for the Period 2009–2013
|
Yordanov, N.R.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 89 |
Inhibition of the Focal Adhesion Kinase Has Anti-Tumoral Effect in Small-Cell Lung Cancer Cell Lines
|
Aboubakar, F.
|
|
|
26 |
S1 |
p. i17
|
artikel
|
| 90 |
Interstitial Lung Disease On Chest Computed Tomography is Associated With the Development of Lung Cancer
|
Kakal, K.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 91 |
Investigating the Utility of Circulating-Free Tumour-Derived Dna (CTDNA) in Plasma for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutation Status in European and Japanese Patients (PTS) with Advanced Non-Small-Cell Lung Cancer (ANSCLC): Assess Study
|
Reck, M.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 92 |
Is Routine Sampling of the Inferior Mediastinal Lymph Node Stations a Necessity for Pre-Operative Mediastinal Staging in Lung Cancer? Results of a Large Retrospective Study of 986 Surgical Resections
|
Evison, M.
|
|
|
26 |
S1 |
p. i15
|
artikel
|
| 93 |
Is Switch Maintenance Therapy Mandatory for EGFR Mutated Patients Initiated on Chemotherapy?
|
Roy, R.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 94 |
Kif5B & Ccdc6 Ret in Lung Cancer: Clinical Insights and Response to Personalized Based Therapy
|
Sarfaty, M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 95 |
Long-Term Survival in Adults Suffered from Malignant Mesothelioma and Pulmonary Tuberculosis Combined - Observational Study
|
Rybacka-Chabros, B.U.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 96 |
Lung Cancer in Women, a Different Disease: Survival Differences by Sex
|
Ulas, A.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 97 |
Maintenance Pemeterexed in Nsclc - Outcome Analysis from a Tertiary Care Center
|
Pandey, A.V.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 98 |
Malignant Pleural Effusion Biomarkers as Predictor for Chemical Pleurodesis Success
|
Alsayed, S.R.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 99 |
Mesenchymal Tumors of the Mediastinum and the Role of Surgery in Their Treatment
|
Caushi, F.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 100 |
Microrna Expression Profiling in Lung Cancer and Normal Tissue Using Massively Parallel Sequencing Technique
|
Lee, H.-Y.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 101 |
Mir31-3P Expression in Patients with Advanced Lepidic Adenocarcinoma (L-ADC) Treated with EGFR Tki in Ifct 0401 and 0504 Trials
|
Thiebaut, R.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 102 |
Misdiagnosis of Lung Tuberculosis Leads to Delaying in Lung Cancer Diagnosis and Treatment: Time to Use Anti-Tuberculosis Treatment Judiciously
|
Devgan, R.K.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 103 |
Mrna Expression Level of Lymphangiogenesis-Associated Genes in Early-Stage Non-Small Cel Lung Cancer
|
Kowalczuk, O.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 104 |
Multiparameter Ploidy Profiling: a Powerful Tool to Investigate the Genomics of Diploid Tumor Populations
|
Lorber, T.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 105 |
New Therapeutic Approach for Mesothelioma
|
Sakata, Y.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 106 |
Occurrence of Significant Tumor Volume Changes During Stereotactic Body Radiation Therapy for Lung Cancer
|
Charlier, F.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 107 |
Omission of Elective Nodal Irradiation Has No Impact on Isolated Elective Nodal Failure and Survival Outcomes in Stage Iii Non-Small-Cell Lung Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy
|
Topkan, E.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 108 |
Open-Label Single-Arm Phase Iv Study to Assess the Efficacy and Safety of Afatinib as Second-Line Therapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harbouring Common Epidermal Growth Factor Receptor (EGFR) Mutations (DEL19 AND/OR L858R) Who Have Failed First-Line Treatment with Platinum-Based Chemotherapy
|
Thongprasert, S.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 109 |
Optimization of Gross Tumour Volume Definition and Treatment Planning in Lung-Sparing Volumetric Modulated Arc Therapy for Pleural Mesothelioma
|
Botticella, A.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 110 |
Outcome After Sbrt for Potentially Operable Nsclc Patients
|
Rossi, M.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 111 |
Outcome of Early-Stage Lung Cancer Treated with Stereotactic Body Radiotherapy (SBRT)
|
Alameddine, M.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 112 |
Outcome of Surgical Salvage for Local Failures Following Stereotactic Ablative Radiotherapy (SABR)
|
Verstegen, N.E.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 113 |
Outcomes of Octogenarian (≥80 YO) Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): a Single Institution Experience from the Christie Hospital
|
Howell, M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 114 |
Outcomes Over a Decade in Stage IV Non-Small Cell Lung Cancer (NSCLC): the Clatterbridge Cancer Centre Experience
|
Escriu, C.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 115 |
Overall Survival (OS) with Afatinib (A) Vs Chemotherapy (CT) in Patients (PTS) with Nsclc Harbouring EGFR Mutations (MUT): Subgroup Analyses by Race in Lux-Lung 3 (LL3) and Lux-Lung 6 (LL6)
|
Schuler, M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 116 |
Passive Smoke Exposure is not a Significant Risk Factor in the Development of Lung Cancer
|
Virdi, R.P.S.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 117 |
PD1/PD-L1 Expression in Nsclc Differs According to Localisation, Grading and Subtype
|
Brühl, F.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 118 |
Perception of Lung Cancer (LC) Risk: Impact of Smoking Status and Nicotine Dependence
|
Greillier, L.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 119 |
Pharmacogenetics & Treatment Outcome in Cancer Patients Receiving Radio-Chemotherapy
|
Yadav, S.S.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 120 |
Phase 2, Open-Label, International, Non-Comparative Study of MEDI4736 in Patients with Locally Advanced or Metastatic, Pd-L1 +, Stage 3B–4 Nsclc Who Have Received ≥2 Prior Systemic Treatment Regimens (ATLANTIC)
|
Gray, J.E.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 121 |
Phase 1/2 Study of Ap26113 in Patients (PTS) with Advanced Malignancies, Including Anaplastic Lymphoma Kinase (ALK)–Positive Non-Small Cell Lung Cancer (NSCLC): Analysis of Safety and Efficacy at Selected Phase 2 Doses
|
Rosell, R.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 122 |
Phase 2 Study of Nivolumab (ANTI-PROGRAMMED DEATH-1 [PD-1]) in Patients (PTS) with Advanced, Refractory Squamous (SQ) Non-Small Cell Lung Cancer (NSCLC)
|
Zalcman, G.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 123 |
Plasma CRABP2 in Patients with Non-Small Cell Lung Cancer
|
Han, S.-S.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 124 |
Platinum Based Chemotherapy for the Treatment of Elderly Patients with Metastatic Non Small Cell Lung Carcinoma: a Retrospective Analysis of a Single Institution
|
Amaadour, L.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 125 |
Pleural Malignant Mesotheliomas Over-Express Pd-L1
|
Voss, A.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 126 |
Post-Operative Outcomes in Non-Small Cell Lung Cancer Patients with Mild to Moderate Stage Chronic Obstructive Pulmonary Disease
|
Itotani, R.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 127 |
Post-Surgical Follow-Up for Non-Small Cell Lung Carcinoma (NSCLC): Challenging Current Practice
|
Iqbal, F.M.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 128 |
Post-Treatment Effects of Lung Cancer on Spinal Fracture
|
Tagbarha, M.O.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 129 |
Predicting Early Lung Cancer Using Big Data
|
Ge, Y.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 130 |
Preoperative Positron Emission Tomography Fractal Biopsy of Thymic Epithelial Neoplasm
|
Bertolaccini, L.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 131 |
Presentation and Patterns of Care of Lung Cancer Patients with Brain Metastasis at a Tertiary Care Centre in India
|
Tibdewal, A.R.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 132 |
Pretreatment Serum Albumin Level is an Independent Prognostic Biomarker in Malignant Pleural Mesothelioma
|
Klikovits, T.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 133 |
Prognosis of Stage III Non-Small-Cell Lung Cancer Patients Presenting with Isolated Brain Failure After Definitive Concurrent Chemoradiation Therapy
|
Topkan, E.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 134 |
Prognostic Classification of Lung Adenocarcinoma by Integrated Mirna-Mrna Expression Profiles
|
Tam, S.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 135 |
Prognostic Influence of Mutational Status in Resected Non-Small Cell Lung Cancer: the KRAS G12V Worse Value
|
Renaud, S.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 136 |
Prognostic Role of T-Regulatory Cells in Completely Resected Early Stage Non-Small Cell Lung Carcinoma
|
Kose, F.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 137 |
Proposed New Simple Criteria of Clinical Multiple Primary Lung Cancers
|
Matsunaga, T.
|
|
|
26 |
S1 |
p. i15
|
artikel
|
| 138 |
Quality in Lung Cancer Care: the Victorian Lung Cancer Registry Pilot Initial Report
|
Stirling, R.G.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 139 |
Radiation Therapy (RT) in the Palliative Treatment of Metastatic Small Cell Lung Cancer (SCLC)
|
Ragulin, Y.
|
|
|
26 |
S1 |
p. i17
|
artikel
|
| 140 |
Randomized, Double-Blind, Placebo-Controlled Trial of Evofosfamide (TH-302) in Combination with Pemetrexed in Advanced Non-Squamous Non-Small Cell Lung Cancer
|
Goldman, J.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 141 |
Reliable EGFR Mutation Testing in Ultrasound Guided Supraclavicular Lymph Node Fine Needle Aspirates: a Cohort Study With Diagnostic Performance Analysis
|
Awwad, A.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 142 |
Result of the 6-Minute Walk Test is an Independent Prognostic Factor of Surgically Treated Non-Small Cell Lung Cancer
|
Marjanski, T.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 143 |
Reversible Versus Irreversible EGFR Tyrosine-Kinase Inhibitors for Non-Small-Cell Lung Cancer (NSCLC): a Preclinical and Pharmacokinetic Comparison
|
Liederer, B.M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 144 |
Review of Radical Radiotherapy +/- Chemotherapy for Stage III Nsclc
|
Button, M.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 145 |
Risk Factors for Skeletal-Related Events in Patients with Non-Small Cell Lung Cancer Patients with Bone Metastases
|
Ulas, A.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 146 |
Role of Treatment in International Differences in One-Year Mortality From Early Stage Non-Small Cell Lung Cancer: a Tentative Answer From the International Cancer Benchmarking Partnership Study
|
Solomon, T.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 147 |
Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis
|
Tfayli, A.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 148 |
Serum Carcinoembryonic Antigen Levels Predicts the Efficacy of EGFR-TKI in Non-Small Cell Lung Cancer Harboring EGFR Mutations
|
Zhang, Y.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 149 |
Sex Differences in Presentation, Management and Prognosis of Moroccan Patients with Non Small Cell Lung Carcinoma: a Retrospective Analysis of 224 Cases
|
Amaadour, L.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 150 |
Significance of Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Nsclc Treated with Pemetrexed Based Chemotherapy
|
Mielgo, X.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 151 |
Single Organ Metastatic Disease, a New Prognostic Factor for Overall Survival (OS) in Stage IV Non-Small Cell Lung Cancer (NSCLC)
|
Hendriks, L.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 152 |
Snps in Angiogenic Factors As Predictive Markers for Outcome in Patients (P) with Advanced Non-Squamous Nsclc (NS-NSCLC) Treated with Carboplatin, Paclitaxel (CP) and Bevacizumab (BEV). Final Results of Angiomet Spanish Lung Cancer Group Trial
|
Massuti Sureda, B.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 153 |
Social Deprivation and Radical Treatment of Stage III Nsclc
|
Button, M.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 154 |
Solitary Fibrous Tumors of the Pleura: Surgical Treatment, Analysis of Our Cases from September 1999 to August 2014
|
Gradica, F.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 155 |
Spectalung: Screening Patients with Thoracic Tumors for Efficient Clinical Trial Access
|
Besse, B.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 156 |
Statin Use and Survival in Malignant Pleural Mesothelioma (MPM)
|
Cedres, S.
|
|
|
26 |
S1 |
p. i48
|
artikel
|
| 157 |
Stereotactic Ablative Radiotherapy (SART) of Lung Lesion in Oligometastatic Patients: the Importance of High Doses Delivery
|
Scotti, V.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 158 |
Subgroup Analysis of Elderly Patients in Squire: a Randomized, Multicenter, Open-Label, Phase Iii Study of Necitumumab (N) Plus Gemcitabine-Cisplatin (GC) Chemotherapy Versus Gc Alone in First-Line Treatment of Patients (PTS) with Stage Iv Squamous Non-Small Cell Lung Cancer (SQ-NSCLC)
|
Thatcher, N.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 159 |
Surgical Treatment of Mediastinal Neurogenic Tumors and Dumbell Syndrome in Adults: a 12-Year Experience, January 2002 to January 2014
|
Gradica, F.
|
|
|
26 |
S1 |
p. i51
|
artikel
|
| 160 |
Surgical Treatment of Synchronous Lung Metastasis in Patient with Osteosarcomas and Soft Tissue Sarcomas
|
Smolenov, E.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 161 |
Synergistic Effect of Histone Deacetylase Inhibitor in Combination with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Egfr-Tki Resistant Non-Small Cell Lung Cancer Cell Lines
|
Han, X.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 162 |
Table of Contents
|
|
|
|
26 |
S1 |
p. v
|
artikel
|
| 163 |
Targeted Therapy for Braf-Mutant Lung Cancer: Results from the European Euraf Cohort Study
|
Gautschi, O.
|
|
|
26 |
S1 |
p. i57
|
artikel
|
| 164 |
Tartrate-Resistant Acid Phosphatase Isoform 5B (TRACP 5B) As Serum Marker of Bone Metastases From Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer. Preliminary Results
|
Lumachi, F.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 165 |
TG4010 Immunotherapy Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC). Phase 2B Results of the Time Study
|
Quoix, E.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 166 |
The Beliefs, Orientation, Knowledge, Understanding, Attitudes and Treatment Access to Lung Cancer Amongst Rural Men in Nigeria
|
Tagbarha, M.O.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 167 |
The Clinical Characteristics of 50 Patients with Radiation Pneumonitis
|
Liu, R.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 168 |
The Comparative Estimation of Estrogen Receptor Beta Expression in Primary and Metastatic Lung Cancer
|
Bogush, T.A.
|
|
|
26 |
S1 |
p. i1
|
artikel
|
| 169 |
The Comparative Estimation of TUBB3 Expression in Non-Small-Cell Lung Carcinoma and Adjacent Lung Tissue
|
Bogush, T.A.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 170 |
The Effect of Emergency Presentation on Surgery and Survival in Lung Cancer Patients in England, 2006-2008
|
Tataru, D.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 171 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
26 |
S1 |
p. vi
|
artikel
|
| 172 |
The Impact of Genetic Alteration on Recurrence in Patients with Resected Stage I Non-Small Cell Lung Cancer
|
Chung, H.S.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 173 |
The Risk of Lung Cancer Among Women Who Start Smoking As Teenagers
|
Tagbarha, M.O.
|
|
|
26 |
S1 |
p. i6
|
artikel
|
| 174 |
The Utility of Actinin-4 Protein Overexpression as a Predictive Biomarker for Therapeutic Effect of Adjuvant Chemotherapy to the Resected Lung Adenocarcinoma
|
Shiraishi, H.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 175 |
The Volume Matters in Stage Iii Nsclc Patients Treated with Concurrent Chemoradiotherapy
|
van Diessen, J.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 176 |
Thirty and 90-Day Mortality After Lung Cancer Resection in 2242 Patients
|
Frick, A.E.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 177 |
Title Page
|
|
|
|
26 |
S1 |
p. iv
|
artikel
|
| 178 |
Transarterial Chemoembolisation Using Drug-Eluting Microspheres Dem-Tace in Lung Carcinoma Metastases to the Liver in Humans
|
Rybacka-Chabros, B.U.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 179 |
Translational Research Index
|
|
|
|
26 |
S1 |
p. i56
|
artikel
|
| 180 |
Trimodality Therapy Including Radical Resection for Pancoast Tumors: T4 is not a Contraindication for Radical Surgery
|
Hoda, M.A.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
| 181 |
TTF1 Expression in Advanced Non-Small Cell Lung Cancer: Impact on Survival Outcome
|
Elsamany, S.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 182 |
Upregulated Mirna 21 in Kras Mutated Patients is Related to Prognosis in Resectable Non-Small Cell Lung Cancer
|
Gallach, S.
|
|
|
26 |
S1 |
p. i10
|
artikel
|
| 183 |
Usefulness of Lung Palpation Through Thoracotomy for Metastasectomy in Patients with Non-Imaged Pulmonary Nodules
|
Lumachi, F.
|
|
|
26 |
S1 |
p. i45
|
artikel
|
| 184 |
Volume Changes with Hypo-Fractionated Radiotherapy in Early Lung Cancer: Time Trends & Outcomes
|
Pathak, R.S.
|
|
|
26 |
S1 |
p. i18
|
artikel
|
| 185 |
Weekly Carboplatin and Paclitaxel in Advanced Non-Small Cell Lung Cancer: Good Response Rate But Poor Overall Survival in a “Real World” Population
|
Mark, M.
|
|
|
26 |
S1 |
p. i29
|
artikel
|
| 186 |
What to Do for the Treatment of Non Small Cell Lung Cancer (NSCLC) with a Single Mediastinal Lymph Node Involvement (N2A DISEASE) in Developing Countries?
|
Caushi, F.
|
|
|
26 |
S1 |
p. i24
|
artikel
|
Tijdschrift beschrijving